Doug Schenkel
Stock Analyst at Wolfe Research
(3.59)
# 688
Out of 4,825 analysts
66
Total ratings
52.08%
Success rate
34.1%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $51.85 | +15.72% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $57.28 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $37.83 | +58.63% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $20.77 | +34.81% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $210.26 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $137.20 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.04 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $196.86 | +44.77% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $39.38 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $106.46 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $42.21 | +22.01% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $8.10 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $76.51 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $47.16 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $419.89 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.13 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $92.94 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.11 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.99 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $48.87 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $151.36 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $343.91 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.01 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.04 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.94 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.38 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.06 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.87 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.34 | +669.23% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $19.98 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $251.59 | -64.23% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.77 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $214.03 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $70.26 | -77.23% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $51.85
Upside: +15.72%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $57.28
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $37.83
Upside: +58.63%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $20.77
Upside: +34.81%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $210.26
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $137.20
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.04
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $196.86
Upside: +44.77%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $39.38
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $106.46
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $42.21
Upside: +22.01%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $8.10
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $76.51
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $47.16
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $419.89
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.13
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $92.94
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.11
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.99
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $48.87
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $151.36
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $343.91
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.01
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.04
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.94
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.38
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.06
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.87
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.34
Upside: +669.23%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $19.98
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $251.59
Upside: -64.23%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.77
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $214.03
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $70.26
Upside: -77.23%